ReoPro (abciximab) to inhibit blood clotting

January 1996

You'll hear more about using ReoPro (abciximab) to inhibit blood clotting.

This biotech drug came out earlier this year in the U.S. Lilly expects to market it soon in Canada as well.

ReoPro is for patients undergoing balloon angioplasty...to help keep the coronary artery open.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

momentum building for providing "Continuity of Care."
Diabetes acarbose, a novel drug for type II, or non-insulin-dependent, diabetes
Anticoagulants patients monitor their own warfarin therapy AT HOME
Anticoagulants using the clot-buster t-PA (Activase) for stroke
Anticoagulants ReoPro (abciximab) to inhibit blood clotting
approving the antihistamine clemastine (Tavist) for cold symptoms
Hematology & Oncology limit tamoxifen use to 5 years
Hematology & Oncology Roche is now marketing Vesanoid
Oral Health some people get fewer canker sores when they switch to a toothpaste that DOESN'T contain sodium lauryl sulfate (SLS)
Oral Health Trental (pentoxifylline) for SEVERE cases of recurrent canker sores
Avonex (interferon beta-1a) for multiple sclerosis
some physicians will prescribe TWO nicotine patches a day
Cholesterol proof that lowering cholesterol reduces the risk of a first heart attack
Cholesterol one cholesterol test isn't enough to determine a patient's cholesterol level
Cardiology the recent concerns about calcium blockers decreasing survival
Ritalin (methylphenidate) for ADHD